Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ANGIODYNAMICS, INC.

(ANGO)
  Report
Delayed Quote. Delayed Nasdaq - 10/18 04:00:00 pm
27.23 USD   -0.51%
10/18INSIDER SELL : Angiodynamics
MT
10/15Health Care Stocks Easing Slightly in Late Trade
MT
10/15Health Care Stocks Advancing With Rising Friday Markets
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo AngioDynamics, Inc.
AngioDynamics, Inc. designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease, vascular access and for use in oncology and surgical settings. Its devices are used in minimally invasive, image-guided procedures. Its product offerings include Endovascular Therapies, Oncology/Surgery (OS) and Vascular Access (VA). Its Endovascular Therapies product offerings support the medical areas of Thrombus Management, Atherectomy, Peripheral Products (Core) and Venous Insufficiency. Its OS product offerings includes a range of ablation technologies, including thermal tissue ablation systems, surgical resection and the Irreversible Electroporation (IRE) technology, the NanoKnife System. Its portfolio of VA products includes peripherally inserted central catheters (PICCs), midline catheters, implantable ports, dialysis catheters and related accessories and supplies.

Number of employees : 800 people.
Sales per Business
20202021Delta
Endovascular Therapies112.7142.7%135.0846.4% +19.85%
Vascular Access94.3035.7%101.3134.8% +7.43%
Oncology/Surgery57.1521.6%54.6218.8% -4.43%
USD in Million
Sales per region
20202021Delta
United States207.9878.7%237.0481.5% +13.97%
International56.1821.3%53.9718.5% -3.93%
USD in Million
Managers
Name Title Age Since
James Christopher Clemmer President, Chief Executive Officer & Director 56 2016
Stephen A. Trowbridge Chief Financial Officer & Executive Vice President 45 2021
David D. Helsel SVP-Global Operations, Research & Development 56 2017
Kim L. Seabury Senior Vice President-Information Technology 53 2011
Juan Carlos Serna Senior VP-Scientific & Clinical Affairs - 2020
Howard W. Donnelly Independent Non-Executive Chairman 59 2014
Dennis S. Meteny Independent Director 67 2012
Wesley E. Johnson Independent Director 62 2012
Eileen O'Shea Auen Independent Director 57 2016
Jan Stern Reed Independent Director 60 2016
Members of the board
Name Title Age Since
Howard W. Donnelly Independent Non-Executive Chairman 59 2014
Dennis S. Meteny Independent Director 67 2012
Wesley E. Johnson Independent Director 62 2012
James Christopher Clemmer President, Chief Executive Officer & Director 56 2016
Eileen O'Shea Auen Independent Director 57 2016
Jan Stern Reed Independent Director 60 2016
Karen A. Licitra Independent Director 61 2019
Michael E. Tarnoff, Dr. Independent Director 51 2019
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 39,020,434 36,875,756 94.5% 370,000 0.9% 94.5%
Shareholders
NameEquities%
Dimensional Fund Advisors LP 2,831,740 7.37%
The Vanguard Group, Inc. 2,459,744 6.40%
Victory Capital Management, Inc. (Investment Management) 2,362,975 6.15%
Fidelity Management & Research Co. LLC 1,900,000 4.94%
SSgA Funds Management, Inc. 1,883,694 4.90%
Millennium Management LLC 1,605,273 4.18%
Lazard Asset Management LLC 1,556,054 4.05%
Gilder, Gagnon, Howe & Co. LLC 1,536,793 4.00%
Wells Capital Management, Inc. 1,206,878 3.14%
Adage Capital Management LP 1,200,000 3.12%
Company contact information
AngioDynamics, Inc.
14 Plaza Drive
Latham, NY 12110

Phone : +1.518.795.1400
Fax : +1.518.795.1401
Web : http://www.angiodynamics.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of AngioDynamics, Inc.